|Articles|March 2, 2016
DrugDev, Exostar Collaborate on Linked Identifiers
The collaboration will allow joint customers to securely combine data from all site-facing applications using single sign-on with non-site facing data sources.
Advertisement
DrugDev and Exostar will combine their unique global identifiers for clinical operations personnel and facilities to address identity credential duplication and missing or incorrect records in systems.
Exostar offers SAM, a turnkey, cloud-based identity and access management solution that delivers single sign-on application access with multi-factor authentication. DrugDev provides its universal identifier called the DrugDev Golden Number for tracking persons and facilities across multiple data sources. The linkage will allow joint customers to securely combine data from all site-facing applications using single sign-on with non-site facing data sources.
Read the full release .
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- How Sponsors Can Modernize Tools to Support Physicians
September 9th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief Episode 7: Veeva and Merck Trial Efficiency, DCT Barriers, and Glucose Monitoring Strategies
2
Summit Therapeutics’ Bispecific Antibody Shows Positive Survival Trend in Non-Small Cell Lung Cancer
3
Pfizer, BioNTech’s Comirnaty Shows Strong Immune Response in Phase III Trial for COVID-19
4
Beyond the Algorithm: How Human-Centered AI Design Can Drive Clinical Trial Success
5